Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Press Release
The 10th Annual FDA/ADVAMED Medical Devices and Diagnostics Statistical Issues Conference, taking place on April 26,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
The Central Monitoring Workgroup will feature speakers from several solution providers who will each present and...
- Press Release
We’re thrilled to announce that version 1.11.0 of CluePoints’ Central Monitoring platform, the enabling SaaS platform...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring solutions for clinical trials, today announced...
- Press Release
We’re thrilled to announce that CluePoints has been named as finalists for the Clinical Informatics News...
- Press Release
The 8th Annual SCOPE Summit for Clinical Ops Executives, taking place on January 24-26, 2017 in...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) and Risk-Based Monitoring(RBM) solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Centralized Statistical Monitoring (CSM)...
- Press Release
Cambridge, MA – FDA and its stakeholders have an interest in assuring the integrity of clinical...
- Press Release
We’re delighted to announce that are our next Risk-Based Monitoring implementation webinar is open for registration!...
- Press Release
The CluePoints and OmniComm Risk-Based Monitoring Implementation Roadshow is Coming to a City Near You! In...
- Press Release
King of Prussia, PA – December 13, 2022: RBQM leader, CluePoints, has today announced Andy Cooper...
- Press Release
King of Prussia, PA – October 12th, 2022: Risk-based quality management (RBQM) solutions provider, CluePoints, is...
- Press Release
According to CluePoints Senior Vice President John Hall, “Federated learning is a critical evolution in the...
- Press Release
King of Prussia, PA – April 11, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – April 5, 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – 7th March 2022: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
John Hall, Senior Vice President, EU, and APAC, at CluePoints, will share insights into delivering successful...
- Press Release
King of Prussia, PA: Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has...
- Press Release
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical...
- Press Release
Steve Young, Chief Scientific Officer at CluePoints, will take to the podium at this year’s CNS...
- Press Release
John Hall, SVP Business Development at CluePoints will share insights into the dimensions of risk associated...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Featured Article
A conversation with Steve Young, member of Avoca Quality Consortium, PHUSE Working Group participant, and Tufts...
Source: Clinical Leader
- Featured Article
The pharmaceutical industry has a problem – a failure to provide women with C-suite opportunities.
...Source: International Clinical Trials
- Featured Article
The ICH E6(R3) draft guideline document, currently open to public consultation, places the industry firmly in...
Source: Applied Clinical Trials
- Featured Article
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of...
Source: CenterWatch
- Featured Article
Central monitoring aims to detect emerging quality-related risks proactively during a clinical trial, resulting in study...
Source: Applied Clinical Trials
- Featured Article
Using key risk indicators (KRIs) can improve clinical trial data quality in 80% of the sites...
Source: Applied Clinical Trials
- Featured Article
Since the release of ICH E6(R2), multiple efforts have been made to interpret the requirements and...
- Read
Source: Springer Link
- Featured Article
An expectation for the use of quality tolerance limits (QTLs) was formally established in the International...
Source: Applied Clinical Trials
- Featured Article
Clinical research is evolving rapidly, with the digitalization of trials creating a new modus operandi and...
Source: Applied Clinical Trials
- Featured Article
Risk-based approaches to monitoring clinical trials were brought to the forefront with an FDA guidance published...
Source: Applied Clinical Trials
- Featured Article
Key risk indicators (KRIs) are metrics designed to identify risks of specific interest to study teams...
Source: Applied Clinical Trials
- Featured Article
The success of clinical development programmes, drug approval and marketing depends ultimately on the readability and...
Source: International Clinical Trials
